- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Jubilant Pharmova Ltd (JUBA)
Jubilant Pharmova Ltd stock price live, this page displays NSE JUBA stock exchange data. View the JUBA premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Jubilant Pharmova Ltd real time stock price chart below.
What Is the Jubilant Pharmova Ltd Stock Price Today?
The Jubilant Pharmova Ltd stock price today is 865.80.
What Is the Stock Symbol for Jubilant Pharmova Ltd?
The stock symbol for Jubilant Pharmova Ltd is "JUBA."
What Stock Exchange Does Jubilant Pharmova Ltd Trade On?
Jubilant Pharmova Ltd is listed and trades on the NSE stock exchange.
Is Jubilant Pharmova Ltd a Good Stock to Buy?
Determining whether Jubilant Pharmova Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the JUBA quote. (ISIN: INE700A01033)
What Is the Jubilant Pharmova Ltd Stock Price Today?
The Jubilant Pharmova Ltd stock price today is 865.80.
What Is the Stock Symbol for Jubilant Pharmova Ltd?
The stock symbol for Jubilant Pharmova Ltd is "JUBA."
What Stock Exchange Does Jubilant Pharmova Ltd Trade On?
Jubilant Pharmova Ltd is listed and trades on the NSE stock exchange.
Is Jubilant Pharmova Ltd a Good Stock to Buy?
Determining whether Jubilant Pharmova Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the JUBA quote. (ISIN: INE700A01033)
865.80
-24.70(-2.77%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
860.00
894.95
52 wk Range
786.05
1,184.80
JUBA is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
860.00894.95
52 wk Range
786.051,184.80
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.56%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.56%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
JUBA Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
RSI suggests the stock is in oversold territory
Jubilant Pharmova Earnings miss, Revenue beats In Q2- Investing.com
- Jubilant Pharmova Earnings miss, Revenue beats In Q2
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Earnings
Latest Release
Aug 10, 2026
EPS / Forecast
3.50 / --
Revenue / Forecast
22.29B / 22.62B
Compare JUBA to Peers and Sector
Metrics to compare | JUBA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipJUBAPeersSector | |
|---|---|---|---|---|
P/E Ratio | 38.9x | 34.8x | −0.4x | |
PEG Ratio | −1.66 | 0.45 | 0.00 | |
Price/Book | 1.9x | 3.3x | 2.6x | |
Price / LTM Sales | 1.6x | 3.4x | 3.1x | |
Upside (Analyst Target) | 25.7% | 12.4% | 47.8% | |
Fair Value Upside | Unlock | 5.9% | 6.2% | Unlock |
Jubilant Pharmova Limited operates as an integrated pharmaceutical company in India, the Americas, Europe, and internationally. It operates through six segments: Radiopharma; Allergy Immunotherapy; Contract Development and Manufacturing Organisation - Sterile Injectables; Generics; Contract Research Development and Manufacturing Organisation; and Proprietary Novel Drugs. The Radiopharma segment offers radiopharmaceuticals products, which are used in the diagnosis and treatment of pulmonary embolism, cancer, coronary artery disease, and other diseases. Its Allergy Immunotherapy segment provides specialized diagnostic devices for skin testing, as well as venom and allergy immunotherapy products. The Contract Development and Manufacturing Organisation - Sterile Injectables segment offers contract manufacturing services for sterile fill and finish injectables, liquids, ointments, creams, and ampoules. Its Generics segment engages in the development, manufacture, distribution, sale, and marketing of generic formulations for therapeutic areas, such as cardiovascular system, central nervous system, gastrointestinal, antibiotics, and multispecialty. The Contract Research Development and Manufacturing Organisation segment provides drug discovery services and active pharmaceutical ingredients. Its Proprietary Novel Drugs segment offers patient-focused biopharmaceutical services to address unmet medical needs in oncology and autoimmune diseases. The company serves pharmaceutical, biotech, group purchasing organizations, allergists, and hospitals sectors. It sells its products through a network of dealers and distributors. The company was formerly known as Jubilant Life Sciences Limited and changed its name to Jubilant Pharmova Limited in February 2021. Jubilant Pharmova Limited was incorporated in 1978 and is based in Noida, India.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Jubilant Pharmova (JUBA) Stock Price Today?
The Jubilant Pharmova stock price today is 865.80 INR.
What Stock Exchange Does Jubilant Pharmova Trade On?
Jubilant Pharmova is listed and trades on the India National Stock Exchange.
What Is the Stock Symbol for Jubilant Pharmova?
The stock symbol for Jubilant Pharmova is "JUBA."
Does Jubilant Pharmova Pay Dividends? What’s The Current Dividend Yield?
The Jubilant Pharmova dividend yield is 0.56%.
What Is the Jubilant Pharmova Market Cap?
As of today, Jubilant Pharmova market cap is 136.92B INR.
What Is Jubilant Pharmova's Earnings Per Share (TTM)?
The Jubilant Pharmova EPS (TTM) is 22.17.
When Is the Next Jubilant Pharmova Earnings Date?
Jubilant Pharmova will release its next earnings report on Oct 30, 2026.
From a Technical Analysis Perspective, Is JUBA a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Jubilant Pharmova Stock Split?
Jubilant Pharmova has split 1 times.
How Many Employees Does Jubilant Pharmova Have?
Jubilant Pharmova has 5657 employees.
What is the current trading status of Jubilant Pharmova (JUBA)?
As of Aug 15, 2026, Jubilant Pharmova (JUBA) is trading at a price of 865.80 INR, with a previous close of 890.50 INR. The stock has fluctuated within a day range of 860.00 INR to 894.95 INR, while its 52-week range spans from 786.05 INR to 1,184.80 INR.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.